Clinical Trials in San Antonio

Showing 4501-4520 of 14,633 trials

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

NCT03821233

This is a first-in-human, Phase 1, multicenter, open-label, dose-escalation study to establish the maximum-tolerated dose (MTD) or recommended dosage (RD) of ZW49, the investigational agent under study, and to assess the safety and tolerability of ZW49. Eligible patients include those with locally advanced (unresectable) or metastatic HER2-expressing cancers.

HER2-expressing Cancers

Zymeworks BC Inc.112 participantsStarted Apr 2019

Duarte, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +13 more locations

COMPLETEDNA< 1 mile

The INSPIRE-ASP PNA Trial

NCT03697070

The INSPIRE-ASP PNA trial is a cluster-randomized controlled trial of HCA hospitals comparing routine empiric antibiotic stewardship practices with real-time precision medicine computerized physician order entry smart prompts providing the probability that a non-critically ill adult admitted with PNA is infected with a resistant pathogen. Note: that enrolled "subjects" represents 59 individual HCA hospitals that have been randomized.

Pneumonia

Harvard Pilgrim Health Care44,780 participantsStarted Oct 2018

Riverside, California, United States • San Jose, California, United States • Thousand Oaks, California, United States +56 more locations

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

The INSPIRE-ASP PNA Trial

Find Trials by Condition in San Antonio

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

PerQseal® Clinical Study

Early Feasibility Study of the Orion Visual Cortical Prosthesis System

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Islatravir and Methadone Pharmacokinetics (MK-8591-029)